Veracyte, Inc. operates as a genomic diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to identify patients with benign thyroid nodules among those with indeterminate cytopathology results in order to rule out unnecessary thyroid surgery; Percepta Genomic Sequencing Classifier for lung cancer; Envisia Genomic Classifier that help physicians to differentiate idiopathic pulmonary fibrosis from other interstitial lung diseases without the need for surgery; and Prosigna Breast Cancer Prognostic Gene Signature Assay test for assessing risk of distant recurrence. It sells its products through product specialists, account managers, and medical science specialists. Veracyte, Inc. has a strategic collaboration with Johnson & Johnson Innovation and the Lung Cancer Initiative at Johnson & Johnson to advance the development and commercialization of novel diagnostic tests to detect lung cancer at its earliest stages; a research collaboration with Loxo Oncology for the development of therapies for patients with genetically defined cancers; and a collaboration with Johnson & Johnson Services, Inc. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

Date	Fund	Action	%
2022/12/16	ARKK	Sell	0.0075
2022/12/15	ARKK	Sell	0.0151
2022/12/14	ARKK	Sell	0.0254
2022/11/21	ARKW	Sell	0.0761
2022/11/18	ARKW	Sell	0.0012
2022/11/17	ARKW	Sell	0.0368
2022/11/16	ARKW	Sell	0.0126
2022/11/15	ARKW	Sell	0.0512
2022/11/14	ARKW	Sell	0.0661
2022/09/20	ARKG	Buy	0.2318
2022/09/19	ARKG	Buy	0.014
2022/09/14	ARKG	Buy	0.0834
2022/09/13	ARKG	Buy	0.1349
2022/01/21	ARKK	Buy	0.0102
2022/01/20	ARKG	Buy	0.0185
2022/01/07	ARKW	Buy	0.0148
2022/01/07	ARKG	Buy	0.0087
2022/01/06	ARKK	Buy	0.0069
2022/01/05	ARKK	Buy	0.0414
2022/01/04	ARKW	Buy	0.0432
2022/01/04	ARKG	Buy	0.0505
2021/12/29	ARKK	Buy	0.0091
2021/12/28	ARKK	Buy	0.0129
2021/12/27	ARKK	Sell	0.0028
2021/10/27	ARKG	Buy	0.0153
2021/10/26	ARKG	Buy	0.0198
2021/10/25	ARKG	Buy	0.0008
2021/10/22	ARKG	Buy	0.0123
2021/10/21	ARKG	Buy	0.0043
2021/10/20	ARKG	Buy	0.0073